2025 Q3 -tulosraportti
Vain PDF
56 päivää sitten
Tarjoustasot
Euronext Growth Oslo
Määrä
Osto
499
Myynti
Määrä
30 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
-VWAP
Alin
-Vaihto ()
VWAP
Ylin
-Alin
-Vaihto ()
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 12.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 13.11.2025 | |
| 2025 Q2 -tulosraportti | 14.8.2025 | |
| 2025 Q1 -tulosraportti | 10.4.2025 | |
| 2024 Q4 -tulosraportti | 13.2.2025 | |
| 2024 Q3 -tulosraportti | 14.11.2024 |
Datan lähde: FactSet, Quartr
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·1 päivä sittenThis stock will rise minimum 50-75% with a reasonable agreement with A-Z and even more by showing even better operations than now.
·1 päivä sittenWhat will happen if the agreement falls through and does not happen?
·12 t sittenRegarding the short-term price development, in my opinion, it will depend on how good the agreement is and how good management is at selling it. Regarding the price development in 2026, it will depend on the ability to deliver according to the agreement, expansion of the agreement to cover new patient pathways, as well as the announcement of any processes aimed at new Pharma partners. A good agreement should give us 10 kroner, and if they deliver on the aforementioned through 2026, I believe we can see 20 kroner. There is, of course, no guarantee that this will be as good as we hope and believe, which is why the price today is 4.2 and not 7-8.
·2.1.Why does it go to auction over 6-7% ?- ·29.12.2025What's happening now? Is it the case that someone is selling to realize losses before New Year's Eve, only to buy back in again? A bit skeptical that the CEO isn't buying anything. Is it because she is an insider, or could it be part of the agreement that she receives x number of kroner in bonus or similar as an incentive for a deal?
·30.12.2025If she possesses information the market does not have, she cannot buy. - ·22.12.2025Why is gav increasing without me buying/selling anything?
·24.12.2025Because the brokerage fee is often calculated and added to GAV a few days after the trade. I see you increased the position on the 19th. The brokerage fee might have been applied on the 22nd, i.e., after the weekend. 
·22.12.2025What is crucial for the case now is not the exact date of signing, but the wording in the stock exchange announcement. The company writes that negotiations are progressing as planned, that the extension of the timeline is not related to changes in intention or strategy. This likely means that the process is in its final phase, and that only formalities remain with all parties. The company's language suggests that the downside risk is reduced compared to before. At the same time, it seems likely that NHS will further increase its commitment to digital transformation. I personally open up to the possibility that the agreement will have a broader scope than what I previously assumed (intention for more indications, areas etc). The sum of this is a more asymmetrical case: the downside risk is lower, while the potential upside is higher. This changes the risk profile of the project in a positive direction and should provide a basis for a higher valuation going forward. The market must price in an increased probability of an agreement and lower risk. As of now, the company is trading below fair DCF value for only TP and Hitta (given that Hitta starts to grow).
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
Vain PDF
56 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenThis stock will rise minimum 50-75% with a reasonable agreement with A-Z and even more by showing even better operations than now.·1 päivä sittenWhat will happen if the agreement falls through and does not happen?·12 t sittenRegarding the short-term price development, in my opinion, it will depend on how good the agreement is and how good management is at selling it. Regarding the price development in 2026, it will depend on the ability to deliver according to the agreement, expansion of the agreement to cover new patient pathways, as well as the announcement of any processes aimed at new Pharma partners. A good agreement should give us 10 kroner, and if they deliver on the aforementioned through 2026, I believe we can see 20 kroner. There is, of course, no guarantee that this will be as good as we hope and believe, which is why the price today is 4.2 and not 7-8.
- ·2.1.Why does it go to auction over 6-7% ?
- ·29.12.2025What's happening now? Is it the case that someone is selling to realize losses before New Year's Eve, only to buy back in again? A bit skeptical that the CEO isn't buying anything. Is it because she is an insider, or could it be part of the agreement that she receives x number of kroner in bonus or similar as an incentive for a deal?·30.12.2025If she possesses information the market does not have, she cannot buy.
- ·22.12.2025Why is gav increasing without me buying/selling anything?·24.12.2025Because the brokerage fee is often calculated and added to GAV a few days after the trade. I see you increased the position on the 19th. The brokerage fee might have been applied on the 22nd, i.e., after the weekend.
- ·22.12.2025What is crucial for the case now is not the exact date of signing, but the wording in the stock exchange announcement. The company writes that negotiations are progressing as planned, that the extension of the timeline is not related to changes in intention or strategy. This likely means that the process is in its final phase, and that only formalities remain with all parties. The company's language suggests that the downside risk is reduced compared to before. At the same time, it seems likely that NHS will further increase its commitment to digital transformation. I personally open up to the possibility that the agreement will have a broader scope than what I previously assumed (intention for more indications, areas etc). The sum of this is a more asymmetrical case: the downside risk is lower, while the potential upside is higher. This changes the risk profile of the project in a positive direction and should provide a basis for a higher valuation going forward. The market must price in an increased probability of an agreement and lower risk. As of now, the company is trading below fair DCF value for only TP and Hitta (given that Hitta starts to grow).
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Euronext Growth Oslo
Määrä
Osto
499
Myynti
Määrä
30 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
-VWAP
Alin
-Vaihto ()
VWAP
Ylin
-Alin
-Vaihto ()
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 12.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 13.11.2025 | |
| 2025 Q2 -tulosraportti | 14.8.2025 | |
| 2025 Q1 -tulosraportti | 10.4.2025 | |
| 2024 Q4 -tulosraportti | 13.2.2025 | |
| 2024 Q3 -tulosraportti | 14.11.2024 |
Datan lähde: FactSet, Quartr
2025 Q3 -tulosraportti
Vain PDF
56 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 12.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 13.11.2025 | |
| 2025 Q2 -tulosraportti | 14.8.2025 | |
| 2025 Q1 -tulosraportti | 10.4.2025 | |
| 2024 Q4 -tulosraportti | 13.2.2025 | |
| 2024 Q3 -tulosraportti | 14.11.2024 |
Datan lähde: FactSet, Quartr
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenThis stock will rise minimum 50-75% with a reasonable agreement with A-Z and even more by showing even better operations than now.·1 päivä sittenWhat will happen if the agreement falls through and does not happen?·12 t sittenRegarding the short-term price development, in my opinion, it will depend on how good the agreement is and how good management is at selling it. Regarding the price development in 2026, it will depend on the ability to deliver according to the agreement, expansion of the agreement to cover new patient pathways, as well as the announcement of any processes aimed at new Pharma partners. A good agreement should give us 10 kroner, and if they deliver on the aforementioned through 2026, I believe we can see 20 kroner. There is, of course, no guarantee that this will be as good as we hope and believe, which is why the price today is 4.2 and not 7-8.
- ·2.1.Why does it go to auction over 6-7% ?
- ·29.12.2025What's happening now? Is it the case that someone is selling to realize losses before New Year's Eve, only to buy back in again? A bit skeptical that the CEO isn't buying anything. Is it because she is an insider, or could it be part of the agreement that she receives x number of kroner in bonus or similar as an incentive for a deal?·30.12.2025If she possesses information the market does not have, she cannot buy.
- ·22.12.2025Why is gav increasing without me buying/selling anything?·24.12.2025Because the brokerage fee is often calculated and added to GAV a few days after the trade. I see you increased the position on the 19th. The brokerage fee might have been applied on the 22nd, i.e., after the weekend.
- ·22.12.2025What is crucial for the case now is not the exact date of signing, but the wording in the stock exchange announcement. The company writes that negotiations are progressing as planned, that the extension of the timeline is not related to changes in intention or strategy. This likely means that the process is in its final phase, and that only formalities remain with all parties. The company's language suggests that the downside risk is reduced compared to before. At the same time, it seems likely that NHS will further increase its commitment to digital transformation. I personally open up to the possibility that the agreement will have a broader scope than what I previously assumed (intention for more indications, areas etc). The sum of this is a more asymmetrical case: the downside risk is lower, while the potential upside is higher. This changes the risk profile of the project in a positive direction and should provide a basis for a higher valuation going forward. The market must price in an increased probability of an agreement and lower risk. As of now, the company is trading below fair DCF value for only TP and Hitta (given that Hitta starts to grow).
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Euronext Growth Oslo
Määrä
Osto
499
Myynti
Määrä
30 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
-VWAP
Alin
-Vaihto ()
VWAP
Ylin
-Alin
-Vaihto ()
Välittäjätilasto
Dataa ei löytynyt